Stoke Therapeutics (STOK) Q3 2023 Earnings

7NovConfirmed
Q4 2022
Q1 2023
Q2 2023
Q3 2023
-0.7
-0.64
-0.59
-0.53

Details

Expected EPS
-0.63
Actual EPS
-0.55
Surprise EPS
0.08
Surprise Percent
+12.7%

Description

Stoke Therapeutics (STOK) has reported earnings of -0.55 per share for Q3 2023.

0 Comments

Share your thoughts